|
Market Closed -
Euronext Paris
18:55:00 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 379.85 EUR | +1.14% |
|
-1.05% | +3.61% |
| 09-11 | Arizona accuses L'Oreal of concealing cancer risks linked to hair relaxers | RE |
| 09-10 | L'Oreal briefly becomes the CAC 40's top market cap |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 418.42 | +10.15% | 24 | |||||||
| 238.72 | +25.69% | 17 | |||||||
| 526,740.74 | +41.6% | 27 | |||||||
| 3,566.38 | +4.77% | 16 | |||||||
| 177,840 | +26.58% | 25 | |||||||
| 99.69 | +2.87% | 16 | |||||||
| 126.67 | +13.09% | 6 | |||||||
| 83.03 | +45.14% | 15 | |||||||
| 28.7 | +1.56% | 9 | |||||||
| 158,608.7 | +12.25% | 23 | |||||||
| 2.689 | -0.41% | 14 | |||||||
| 272,720 | +0.82% | 25 | |||||||
| 5,563.85 | -0.2% | 13 | |||||||
| 28 | -15.04% | 5 | |||||||
| 9,770 | +27.71% | 2 | |||||||
| 41.28 | +33.28% | 11 | |||||||
| 29.92 | +46.58% | 3 | |||||||
| - | 37,500 | +45.35% | 2 | ||||||
| 303,846.15 | +81.29% | 13 | |||||||
| - | - | 26 | +29.35% | 1 | |||||
| Average | 74,863.95 | +21.62% | 13 | ||||||
| Weighted average by Cap. | 24,465.56 | +14.10% | 22 |
- Stock Market
- Stocks
- OR Stock
- Sector L'Oréal
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















